Patent · US Active

Method of determining dose of erythropoiesis-stimulating agent

US10496794B2 · kind B2 · utility

0Cited by
1References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 7, 2015
Grant dateDec 3, 2019
Priority date
Expiry dateFeb 19, 2038

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG16C20/30
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A method of determining an ESA dose, which allows a hemoglobin concentration in the blood to be stably maintained at a target value, and which can decrease a range of fluctuation of the hemoglobin concentration with respect to the target value. The method comprises the steps of: setting the target value of the hemoglobin concentration in the blood; calculating a target value of a hemoglobin production rate which allows the hemoglobin concentration to reach the target value; calculating a serum ESA concentration which allows the hemoglobin production rate to reach the target value, from a relationship between the hemoglobin production rate and the ESA concentration; and calculating an amount of administration of an ESA which gives the serum ESA concentration, from a relationship between the ESA concentration and the amount of administration of the ESA, to determine an ESA dose which allows the hemoglobin concentration to reach the target value.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.